Analysis of effectiveness of neodymium laser (1064 nm) monotherapy in treatment of erythemato-teleangiectatic rosacea

Rosacea is a chronic skin disease with the polyethological nature, which is found everywhere - the prevalence of this dermatosis in European countries reaches 22 %. The social significance of the disease is due to its progression, a tendency to relapse, and a decrease in the patients quality of life in the absence of supportive corrective therapy. One of the leading roles in the pathogenesis of this disease belongs to vascular pathology, in this regard, local therapy with a neodymium laser with a wavelength of 1064 nm is one of the most optimal methods in terms of efficacy and tolerability, the absence of systemic side effects and having no limitations on the patient s skin type. Materials and methods. Ten patients with confirmed erythematoma-telangiectatic subtype of rosacea participated in the study, of whom 100 % were women. The median age was 55.4 ± 4.3 years. Patients were assigned local monotherapy with a Nd: YAG-laser (1064 nm). To assess the effectiveness, we used the data of the average erythema of the skin of both cheeks using the Multi Skin Test Center MC 750; as well as photo measurement of the vascular component of the facial skin with the help of Reveal Imager (Canfield) system before and 1 week after the completion of the course of therapy; in addition, the results were evaluated according to the IGA dermatological status index (from 0 to 5 points) and the patient s quality of life index (DIQL) as well before and 1 week after the completion of the course of therapy. A total of 3 to 4 sessions of therapy were performed depending on the achievement of the clinical effect. Results. Monotherapy with neodymium laser (1064 nm) has a pronounced therapeutic effect in the treatment of patients with erythematous-telangiectatic rosacea subtype. After the therapy, clinical remission was found in 7 out of 10 patients, in 3 patients out of 10, a significant improvement was achieved, which was confirmed by the positive dynamics of the dermatological status index (IGA), DIQL as well as the data of hardware and photo-measurements. During the treatment no clinically significant side effects were found.

rosacea, teleangiectasia, erythema, laser therapy, neodymium laser

1. Powell F. C., Rosacea. N. Engel J. Med. 2005; 352: 793-803.

2. Del Rosso J. Q., Gallo R. L., Tanghetti E., Webster G., Thiboutot D. An evaluation of potential.

3. Потекаев, Н. Н. Розацеа. СПб.: Невский диалект, 2000. 144 с.

4. Gupta M. A. et al. Comorbidity of rosacea and depression: an analysis of the National Ambulatory Medical Care Survey and National Hospital Ambulatory Care Survey-Outpatient Department data collected by the U. S. National Center for Health Statistics from 1995 to 2002. // Br. J. Dermatol. 2005. Vol. 153, N 6. P. 1176-1181.

5. Elewsky B, Draelos Z, Dreno B. Rosacea - global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group. JEADV 2011; 25: 188-200.

6. Адаскевич, В. П. Акне и розацеа. СПб.: Ольга, 2000. - 132 с.

7. Del Rosso J. Q., Gallo R. L., Tanghetti E. et al. An evaluation of potential correlation between pathophysiologic mechanisms, clinical mani-fes-tations, and management of rosacea. // J Clin Aesthet Dermatol 2012; 5 (3): 16-25.

8. Wilkin J. et al. Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. // J. Am. Acad. Dermatol. 2004. Vol. 50, N 6. P. 907-912.

9. Курдина М. И., Потекаев Н. Н., Самгин М. А. Розацеа. Учебное пособие. 1999; 24 с.

10. Jarmuda S., O'Reilly N., Zaba R., Jakubowicz O., Szkaradkiewicz A., Kavanagh K. Potential role of Demodex mites and bacteria in the induction of rosacea. J Med Microbiol. 2012; 61 (pt 11): 1504-1510.

11. Boixeda de Miquel D. et al. Effect of Helicobacter pylori eradication therapy in rosacea patients. 11 Rev. Esp. Enferm. Dig. 2006. Vol. 98. P. 501-509.

12. Garnis-Jones S. Psychological aspects of rosacea. J Cutan Med Surg 1998; 2 (Suppl. 4): 4-9.

13. Слесаренко Н. А., Леонова М. А., Бакулев А. Л., Давыдова А. В., Слесаренко Н. С., Каткова И. О. Роль Helicobacter pylori как триггерного фактора в развитии розацеа и влияние ее эра-дикации на течение дерматоза // Вестник дерматологии и венерологии. 2012. № 2. С. 33-39.

14. Zouboulis C., Katsambas A., Kligman A. Pathogenesis and Treatment of Acne and Rosacea / ed. Zouboulis C. C., Katsambas A. D., Kligman A. M. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014.

15. Wilkin J., Dahl M., Detmar M., Drake L. et al. Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol. 2002 Apr 46 (4): 584-7.

16. Del Rosso J. Q., Thiboutot D., Gallo R. et al. Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 1,5: 2013.

17. Tan J., Berg M. Rosacea: Current state of epidemiology // J. Am. Acad. Dermatol. 2013. Vol. 69.

18. Crawford GH, Pelle MT, James WD. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol. 2004 Sep; 51 (3): 327-41.

19. Del Rosso J. Q., Gallo R. L., Tanghetti E. et al. An evaluation of potential correlation between pathophysiologic mechanisms, clinical mani-festations, and management of rosacea. Cutis 2013; 91 (suppl 3): 1-8.

20. Powell F.C, Rosacea. N. Engel J. Med. 2005; 352: 793-803.

21. Бауманн Л. «Косметическая дерматология. Принципы и практика», пер. с англ.; под. ред. Потекаева Н. Н. Издательство «МЕДпресс-информ», 2012. 253-261 с.

22. Elewsky B, Draelos Z, Dreno B. Rosacea - global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group. JEADV 2011; 25: 188-200.

23. Потекаев Н.Н., Круглова Л. С. Лазер в дерматологии и косметологии. 2012, М.: МДВ, 51-63 с., 174-177 с.

24. Дейвид Дж. Голберг. Лазеро- и светолечение. Том 2. Омоложение кожи. Лазерная шлифовка. Лазерная терапия у пациентов с темной кожей. Рид Элсивер, 2010.

25. Европейское руководство по лечению дерматологических заболеваний / Под ред. А. Д. Кацам-баса, Т. М. Лотти. 2008, пер. с англ. В. П. Адаске-вича, М.: МЕД-пресс информ, 2014, 736 с.

26. Михайлова Н. А. Лазеры и IPL системы в лечении сосудистой патологии. KOSMETIK international journal, № 2, 2013, стр. 66-73.

27. Alam M, Voravutinon N, Warycha M, et al. Comparative effectiveness of nonpurpuragenic 595nm pulsed dye laser and microsecond 1064-nm neodymium: yttrium-aluminum-garnet laser for treatment of rosacea, J Am Acad Dermatol. Sep 2013; 69 (3): 438-443.